William Dameshek
From Wikipedia, the free encyclopedia
William Dameshek (1900-1969) was an American hematologist. Trained at Harvard, he was the founder of Blood, the prime core clinical journal of hematology, in 1946. He is also credited with describing the concept of myeloproliferative diseases in 1951. In addition, he participated in the first studies of nitrogen mustard in various hematological malignancies, widely considered the first uses of chemotherapy in malignant diseases.
Dr. Dameshek served as president of the American Society of Hematology (ASH) in 1964. He made numerous contributions to ASH as well as the field of hematology and was the first eidtor of its journal Blood. Given Dr. Dameshek's accomplishments, ASH has named the Dameshek Prize in his honor. Each year the Dameshek Prize is awarded to indivdual who has made an outstanding contribuiton in hematology.
[edit] External Links
The American Society of Hematology (http://www.hematology.org/)
[edit] References
- Goodman LS, Wintrobe MM, Dameshek W, Goodman MJ, Gilman A and McLennan MT. Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia, and certain allied and miscellaneous disorders. J Am Med Assoc 1946;105:475-476. Reprinted in JAMA 1984;251:2255-61. PMID 6368885.
 This biographical article related to medicine in the United States is a stub. You can help Wikipedia by expanding it. |
